Prakt. lékáren. 2011; 7(5): 208-211

New possibilities in treating bacterial vaginosis and vaginal discomfort

Pavel Turčan
Ordinace sexuologie a andrologie, Centrum MEDIOL s. r. o., Olomouc

Bacterial vaginosis is one of the most common of vaginal infections in women of childbearing age. It is characterised by an overgrowth

of predominantly anaerobic organisms in the vagina leading to a replacement of lactobacilli and an increase in vaginal pH. Current

treatment of bacterial vaginosis consists in metronidazole, preferably by oral route, or in a topical cream of clindamycin. However, these

treatments do not automatically restore a normal flora characterised by a high concentration of lactobacilli, which facilitates relapses

and recurrences. Femibion® Intima, a new medication, which contains of specific prebiotics and red clover plant extract, appears to be

effective in restoring the vaginal flora after the treatment for a BV episode.

Keywords: vaginal inflammatory diseases, bacterial vaginosis, léčba, lactobacilli, probiotics, prebiotics, restoration of the vaginal flora

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Turčan P. New possibilities in treating bacterial vaginosis and vaginal discomfort. Praktické lékárenství. 2011;7(5):208-211.
Download citation

References

  1. Unzeitig V. Vulvovaginální diskomfort. In.: Fait T, Dvořák V, Skřivánek A, et al. Almanach ambulantní gynekologie. Praha: Maxdorf 2009: 84-90.
  2. Martius G, et al. Gynekologie a porodnictví. Martin, Osveta 1997.
  3. Citterbart K, et al. Gynekologie. Praha: Galén 2001.
  4. Turčan P. Vaginální dysmikrobie. In: Fait T, Slíva J, et al. Volně prodejné přípravky v gynekologii. Praha: Maxdorf 2011: 58-71.
  5. Čepický P. Psychologie ženy. Praha: Dr. P. Čepický 1992.
  6. Nouzová K. Gynekologické péče. Praha: Mladá fronta 2010.
  7. Mašata J, Jedličková A, et al. Infekce v gynekologii. Praha. Maxdorf 2006.
  8. Cribby S, Tailor M, Gregor R. Vaginal microbiota anf the Use of Probiotics. Interdiscip Perspect Infect Dis. 2008: 256-490. Go to original source... Go to PubMed...
  9. Líbalová Z, Čepický P. Vulvovaginitis. Mod Gynek Porod 2005; 4(14): 502-510.
  10. Turčan P. Využití itrakonazolu v léčbě recidivujících vulvovaginitid. Lékařské listy Speciál 2010; 7: 24-26.
  11. Verstraelen H, Verhelst R. Bacterial vaginosis: an update od diagnosis and treatment. Expert Rev. Anti Infect. Ther 2009; 7(9): 1109-1124. Go to original source... Go to PubMed...
  12. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29: 297-301. Go to original source... Go to PubMed...
  13. Pirotta M, Fethers KA, Bradshaw CS. Bacterial vaginosis - More questions than answers. Aust Fam Physician 2009; 38(6): 394-397. Go to PubMed...
  14. John C, et al. Reduced incidence of pretherm delivery with metronidazole and erytromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732-1736. Go to original source... Go to PubMed...
  15. Judlin P. Current concepts in managing pelvic inflammatory disease. Curr Opin Infect Dis 2010; 23(1): 83-87. Go to original source... Go to PubMed...
  16. Ness RB, et al. A Cluster Analysis of Bacterial Vaginosisassociated Microflora and Pelvic Inflammatory Disease. Am J Epidemiol 2005; 162(6): 585-590. Go to original source... Go to PubMed...
  17. Camara M, Hang Y, Ruojin Y. The study of association between bacterial vaginosis and cervical intraepithelial neoplasia at Xiangya Hospitál (Changsha-Hunan, China). Clin Rev Opininons 2011; 3(3): 32-36.
  18. King CC, et al. Bacterial Vaginosis and the Natural History of Human Papillomavirus. Infections Diseases in Obst anf Gyn 2011: 319-460. Go to original source...
  19. Doporučení k diagnostice a terapii vulvovaginitis. Mod Gynek Porod 2007; 16(Suppl. 1): 191-197.
  20. Hay P. Recurrent bacterial vaginosis. Curr Opin Infect Dis 2009; 22(1): 82-86. Go to original source... Go to PubMed...
  21. Donders G. Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet Gynecol Surv 2010; 65(7): 462-473. Go to original source... Go to PubMed...
  22. Tomasik PJ, Tomasik P. Probiotics and Prebiotics. Cereal Chem 2003; 80(2): 113-117. Go to original source...
  23. Anukam K, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes and Infections 2006; 8: 1450-1454. Go to original source... Go to PubMed...
  24. Figueiredo Leite SR, et al. Clinical and microbiological profile of women with bacterial vaginosis. Rev Bras Ginecol Obstet 2010; 32(2): 82-87. Go to original source... Go to PubMed...
  25. Intra vaginal prebiotic treatment in prevention of recurrent BV- A clinical randomised study. Eur J Obstet Gynecol. Submited.
  26. Charalampopoulos D, Rastall RA. Prebiotics and Probiotics Science and Technology. New York: Springer, 2009. Go to original source...
  27. Nithya R, et al. Roles of Glycoproteins and Oligosaccharides Found in Human Vaginal Fluid in Bacterial Adherence. Infect Immun 1999; 67(10): 5027-5032. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.